Cargando…

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders

Primary cutaneous CD30(+) T-cell lymphoproliferative disorders are the second most common cutaneous lymphomas. According to the World Health Organization, CD30(+) T-cell lymphoproliferative disorders include primary cutaneous anaplastic large cell lymphoma (C-ALCL) and lymphomatoid papulosis (LyP) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdulla, Farah R., Zhang, Weiwei, Wu, Xiwei, Honda, Kord, Qin, Hanjun, Cho, Hyejin, Querfeld, Christiane, Zain, Jasmine, Rosen, Steven Terry, Chan, Wing C., Parekh, Vishwas, Song, Joo Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688881/ https://www.ncbi.nlm.nih.gov/pubmed/34977845 http://dx.doi.org/10.1016/j.xjidi.2021.100068

Ejemplares similares

Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides
por: Di Raimondo, Cosimo, et al.
Publicado: (2021)

Reprogramming of PD-1(+) M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma
por: Han, Zhen, et al.
Publicado: (2023)

Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma
por: Jothishankar, Balaji, et al.
Publicado: (2020)

Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
por: Gentile, Michelle S., et al.
Publicado: (2015)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
por: Trum, Nicholas A., et al.
Publicado: (2021)

Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome
por: Di Raimondo, Cosimo, et al.
Publicado: (2022)

CD30+ Primary Cutaneous Post-transplant Lymphoproliferative Disorder with Signet-ring Cell Features
por: Malviya, Neeta, et al.
Publicado: (2016)

Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder
por: Kadin, Marshall E., et al.
Publicado: (2020)

Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
por: Virgen, Cesar A., et al.
Publicado: (2020)

Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity
por: Saleh, Jamal Z., et al.
Publicado: (2016)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Relief of intractable pruritus with romidepsin in patients with cutaneous T‐cell lymphoma: A series of four cases
por: Poligone, Brian, et al.
Publicado: (2019)

Cutaneous metastasectomy: Is there a role in breast cancer? A systematic review and overview of current treatment modalities
por: Huang, Samantha, et al.
Publicado: (2022)

Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil
por: Ferreira, Cristiane Rúbia, et al.
Publicado: (2019)

Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell Lymphoma
por: Petrogiannis-Haliotis, Tina, et al.
Publicado: (2023)

Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
por: Valentim, Flávia de Oliveira, et al.
Publicado: (2019)

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder in an Unusual Location
por: Ruiz-Sánchez, Daniel, et al.
Publicado: (2022)

The enigmatic ear: Unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review
por: Sahraoui, Ghada, et al.
Publicado: (2023)

Cutaneous plasmacytoma: Metastasis of multiple myeloma and invasion of sternotomy scar
por: Carmel, Benjamin, et al.
Publicado: (2018)

Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4+
por: Ardeleanu, Valeriu, et al.
Publicado: (2022)

An Atypical Presentation of Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder
por: Kazan, Didem, et al.
Publicado: (2023)

Romidepsin in the treatment of cutaneous T-cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2011)

Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1
por: Merati, Miesha, et al.
Publicado: (2015)

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
por: Li, Janet Y, et al.
Publicado: (2012)

Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder: A case report
por: Koper, Monika, et al.
Publicado: (2019)

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors()
por: Sarac, Esra, et al.
Publicado: (2023)

Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team
por: Poligone, B, et al.
Publicado: (2015)

Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
por: Wehkamp, Ulrike, et al.
Publicado: (2022)

Cutaneous pseudolymphomatous drug eruption secondary to supplemental flaxseed oil
por: Larson, Emma L., et al.
Publicado: (2022)

Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
por: Wehkamp, Ulrike, et al.
Publicado: (2023)

Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report
por: Amini, Arya, et al.
Publicado: (2021)

COVID-19 Vaccine Pfizer-BioNTech: Recurrence of CD30-positive lymphoproliferative disorder: case report
Publicado: (2021)

Recurrent, Multisubtype Posttransplant Lymphoproliferative Disorder Masquerading as Inflammatory Bowel Disease
por: Mussarat, Saad, et al.
Publicado: (2022)

Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma
por: Zhang, Xu Hannah, et al.
Publicado: (2018)

Novel therapeutic agents for cutaneous T-Cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2012)

Polymerase Chain Reaction-Based Clonality Analysis of Cutaneous B-Cell Lymphoproliferative Processes
por: Melotti, Claudia Z, et al.
Publicado: (2010)

Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient
por: Wang, Hua Xian Elizabeth, et al.
Publicado: (2022)

Differential diagnosis of primary cutaneous CD4+ small/medium T-cell lymphoproliferative lesions: A report of three cases
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_17u6elh9g38ldqf8fbrveb6h65